Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles - Test2 - elhamkhani - TriplyDB

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

http://www.wikidata.org/entity/Q27477687

about

Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain Mechanisms of viral entry: sneaking in the front door Cellular cofactors affecting hepatitis C virus infection and replication Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating Hepatitis C virus proteins The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus Potential cellular receptors involved in hepatitis C virus entry into cells Entry inhibitors: New advances in HCV treatment Metabolic alterations and hepatitis C: From bench to bedside Roles of lipoprotein receptors in the entry of hepatitis C virus Interferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV)Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design New hepatitis C virus drug discovery strategies and model systems Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseases The hepatitis C virus glycan shield and evasion of the humoral immune response Neutralizing antibody response to hepatitis C virus Human Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex Formation Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells.Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.Robust hepatitis C virus infection in vitro.Efficient hepatitis C virus cell culture system: what a difference the host cell makes.Bovine viral diarrhea virus entry is dependent on clathrin-mediated endocytosis Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein Analysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2 Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes.Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay.Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus Molecular virology of hepatitis C virus (HCV): 2006 update Different Domains of CD81 Mediate Distinct Stages of Hepatitis C Virus Pseudoparticle Entry

P2860

Q21089621-E25415C5-9EF2-4650-B0FB-024A6E7AAC14 Q21090524-F6B794F0-2FB4-4BA5-BB70-310AB95831F9 Q22252690-F44ED62C-BCC9-4AB7-BB04-2024618F7425 Q24317564-C9959DA1-9324-4240-810C-3769412F4C29 Q24336433-6395F2A5-24DE-4BD1-87F0-58823FAA68FC Q24562016-B25560CF-92CC-463A-BEE9-5728E84B434A Q24563969-7F36A144-DDE9-40FB-BF86-B52596C0A089 Q24652906-FD8204C0-B825-48C6-9011-C633793D64AC Q24672232-0814282B-ACA7-44E6-A47A-47331F5660A1 Q24676039-B2949D83-C2F8-45B6-9AB7-B0D1719EC686 Q24681592-A9438599-BC23-464C-BAD2-930D4D110B5E Q24795289-4ABFB642-77F5-4685-AE90-DA475D5CC46D Q26770817-C59DE8D6-AF09-4AFE-82A3-BC298B956AA9 Q26773261-49CED6E6-6E1F-46C2-88CD-3E46639F8097 Q26777338-1B84BCCC-3200-4371-ADB4-512ABE741BDE Q26778005-6ADC323A-DB54-4716-A90E-3740E7C4B340 Q26801759-9EB2DEBB-6A44-4D25-8FD4-53A81461144E Q26851159-454A7369-D2C2-4857-8DE7-AC96BCC0342E Q26853500-19E7B81E-90AF-43E1-A283-C4B9D2403BEC Q26992256-C2478D7E-67E1-42E3-9FD8-6E07E67150C3 Q27023390-69AA4EEC-FBB6-4E0D-B204-61E61C2B212F Q27027484-78F6A015-DB5E-4354-A907-C105E23FE8EF Q27468561-71DF5E40-1E17-4AF2-A9B1-CACAFAC07924 Q27469468-3FCC51C1-C2E5-450C-9CD1-FB3BF2FDD3B0 Q27469507-071F6F07-66C6-4103-934B-C0A53D864F81 Q27469837-3A8A1CBD-D5E2-4FC7-99EF-376368A49BC6 Q27469843-966A4D40-440C-47F5-A3C5-EF5341374368 Q27469844-5790065B-6452-46B0-A7CA-146022708643 Q27470013-F353EE0F-3D0F-48B7-8E75-66A39183D6B1 Q27470192-FB2D69C4-2875-4D80-B3DD-49D227852213 Q27470481-7A81071D-C333-46C7-AB25-8EC5AAD3D345 Q27470798-067CAFC1-28EE-4C75-BB4D-BDF46C6F208B Q27472672-8196AE3F-0491-46DA-BC9A-EEDCBBD35373 Q27472765-5ACC9A08-E89A-468A-9CA8-8E4F3BFA59BE Q27472768-4C850934-D16A-4418-8DA2-C9812DD7F5C7 Q27472926-AF84A3F0-C6C2-4602-B22A-C724B3AD42CC Q27472928-75F888B3-AB9C-4AC3-8632-8E16FBA663D0 Q27473047-928A1F75-BECC-47E1-92B4-DEC2F586B729 Q27473115-083DFDC8-AC4A-4A91-9995-F11C6A1A5683 Q27473222-FB610DAF-C7E6-4D00-B19D-0329D0648BF6

P2860

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

http://www.wikidata.org/entity/Q27477687

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Hepatitis C virus glycoprotein ...... eudotyped retroviral particles

@ast

Hepatitis C virus glycoprotein ...... eudotyped retroviral particles

@en

Hepatitis C virus glycoprotein ...... eudotyped retroviral particles

@nl

type

label

Hepatitis C virus glycoprotein ...... eudotyped retroviral particles

@ast

Hepatitis C virus glycoprotein ...... eudotyped retroviral particles

@en

Hepatitis C virus glycoprotein ...... eudotyped retroviral particles

@nl

prefLabel

Hepatitis C virus glycoprotein ...... eudotyped retroviral particles

@ast

Hepatitis C virus glycoprotein ...... eudotyped retroviral particles

@en

Hepatitis C virus glycoprotein ...... eudotyped retroviral particles

@nl

P1433

Q27477687-BDEF676E-4026-472D-9397-4C9F012C9A9C

P1476

Q27477687-B02C1B90-2B5A-4DDE-A75B-4220733D87A7

P2093

Q27477687-0CA0A34E-7926-4A5F-9525-334B5C4A0885

Q27477687-A8874102-394B-44FC-86E4-A16AD63FD292

Q27477687-B53CDB70-D5F8-480C-A52F-84BD6AF58817

Q27477687-D103AD56-6D74-43E5-8F97-1253C45CA715

P2860

Q27477687-073FF646-561B-41F9-85CA-C27593028F69

Q27477687-0BEB3117-B665-4D32-88A2-ECE5CBD6501E

Q27477687-12A1ABAF-4FBD-4338-A2DE-BFFE0983E121

Q27477687-16E06055-45E0-4D0F-B7AF-8B0C9F801BE7

Q27477687-16ED83DD-5F34-4CE3-97BA-2ACA58A36268

Q27477687-17F4F0D7-3E01-498A-8FDD-01D5B3C3B2B9

Q27477687-19626793-22E4-49F3-B181-3222F8ECA0F7

Q27477687-1A76B763-3E05-4E05-BCF2-F92E8FDDF8B0

Q27477687-1BC9BB6C-2579-499D-A4F0-B2CF1AD344A5

Q27477687-1BF58776-4569-4C38-9424-DC7DB966664E

P304

Q27477687-104694AF-C7EF-49B6-9338-7A8285A68046

P31

Q27477687-B3C56803-DF7B-4794-A9D3-3AF0F1377C57

P3181

Q27477687-ACAD34BC-BB74-4921-A0B5-16F7611A7450

P356

Q27477687-435D1337-D3DF-481C-BF3C-D39549B989EA

P407

Q27477687-9C220E35-2E66-4953-B7E6-D6491538BF5D

P433

Q27477687-2ADD0BD9-ACF4-4E99-A6E7-EC2F3DD9F7C6

P478

Q27477687-5D5ED6CC-7E05-4669-8025-CCD5B7CAF03B

P50

Q27477687-E2B42B81-88C6-47C6-BC17-654BC9370AD7

Q27477687-FBD3DA3D-D7DA-4711-AAE7-FA05D725290C

P577

Q27477687-6C179354-DD37-44B8-AEA8-1616602C8DC4

P5875

Q27477687-3741A392-85D8-4239-AA2E-0DA03409076D

P698

Q27477687-5F7911B3-BA69-483B-97A4-FA99527C980C

P921

Q27477687-91dcc369-4816-e9a3-f682-9796afc36bde

P932

Q27477687-9E9C3487-EE6C-4DC0-8F24-276483600DB9

P3181

P356

PNAS.0832180100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Hepatitis C virus glycoprotein ...... eudotyped retroviral particles

@en

P2093

Carine Logvinoff

http://www.w3.org/2001/XMLSchema#string

Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Mayla Hsu

http://www.w3.org/2001/XMLSchema#string

Mike Flint

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.

Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor

Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus

Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein.

Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.

P304

7271-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2027362

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0832180100

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Jane A. McKeating

Cecilia Cheng-Mayer

P577

2003-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10748767

http://www.w3.org/2001/XMLSchema#string

P698

12761383

http://www.w3.org/2001/XMLSchema#string

P921

Hepatitis C virus

P932

165865

http://www.w3.org/2001/XMLSchema#string